Advertisement

Topics

Can Lilly's Abemaciclib Overcome Third Place Finish In CDK4/6 Race?

18:14 EDT 20 Mar 2017 | SCRIP

Lilly reported positive top-line results for abemaciclib in the Phase III MONARCH 2 trial and revealed a regulatory strategy that...

      

Related Stories

 

Original Article: Can Lilly's Abemaciclib Overcome Third Place Finish In CDK4/6 Race?

NEXT ARTICLE

More From BioPortfolio on "Can Lilly's Abemaciclib Overcome Third Place Finish In CDK4/6 Race?"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...